Spots Global Cancer Trial Database for onivyde
Every month we try and update this database with for onivyde cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Post Marketing Surveillance Study for ONIVYDE® in South Korea | NCT03446872 | Metastatic Panc... | ONIVYDE 5-fluorouracil Leucovorin | 19 Years - | Servier | |
| Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC | NCT03665441 | Pancreatic Aden... | eryaspase Gemcitabine plu... Irinotecan plus... | 18 Years - | ERYtech Pharma | |
| A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma | NCT03483038 | Pancreatic Aden... | Liposomal Irino... FOLFOX regimen | 18 Years - 99 Years | University of Florida | |
| Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma | NCT03719924 | Squamous Cell C... | Onivyde Paclitaxel | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma | NCT03483038 | Pancreatic Aden... | Liposomal Irino... FOLFOX regimen | 18 Years - 99 Years | University of Florida | |
| A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma | NCT03483038 | Pancreatic Aden... | Liposomal Irino... FOLFOX regimen | 18 Years - 99 Years | University of Florida | |
| Post Marketing Surveillance Study for ONIVYDE® in South Korea | NCT03446872 | Metastatic Panc... | ONIVYDE 5-fluorouracil Leucovorin | 19 Years - | Servier | |
| Post Marketing Surveillance Study for ONIVYDE® in South Korea | NCT03446872 | Metastatic Panc... | ONIVYDE 5-fluorouracil Leucovorin | 19 Years - | Servier | |
| Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer | NCT05277766 | Peritoneal Carc... Peritoneal Meta... Colorectal Canc... Small Bowel Can... Appendix Cancer Gastric Cancer Pancreatic Canc... Bile Duct Cance... | PIPAC with Nal-... | 18 Years - | University Hospital, Ghent | |
| Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma | NCT04901702 | Recurrent Solid... Recurrent Ewing... Recurrent Hepat... Recurrent Malig... Recurrent Malig... Recurrent Neuro... Recurrent Osteo... Recurrent Perip... Recurrent Rhabd... Recurrent Rhabd... Recurrent Soft ... Recurrent Wilms... Refractory Ewin... Refractory Hepa... Refractory Mali... Refractory Mali... Refractory Neur... Refractory Oste... Refractory Peri... Refractory Rhab... Refractory Rhab... Refractory Soft... | Onivyde Talazoparib Temozolomide | 12 Months - 30 Years | St. Jude Children's Research Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
